Biospecimen Acquisition and Management Core Prognostex, Inc. provides products to enable uniform collection of high quality human tumor samples from patients with solid tumors. The protocols, kits, and devices were developed in breast cancer research to solve the problem of getting tumor samples for biomarker studies from small breast cancers without compromising pathologic evaluation of the tumor.

RAD-Core Kit Provides all necessary components to facilitate the acquisition and transport of biospecimens at the time of radiologic assessment. Click for more information. OP-Core Kit A custom kit provides all necessary components for sample acquisition at time of definitive surgery. It includes a patented stereotactic tissue holding device which allows similar, clinically transparent tumor acquisition at any surgical site. Click for more information. Stereotactic Core Acquisition Device The stereotactic tissue acquisition device (Op-Core device) was developed to facilitate tumor biopsy, improve user safety, and improve tumor sampling. The surgical specimen is placed ex-vivo in the device and core needle specimens are acquired guided by a radiograph or ultra sound of the tissue in the device. The container also can be used for specimen submission to pathology after placement in a sealed bag. Click for more information.

The products and methodologies developed for breast cancer are valid for other cancers as well, meaning that the products and services offered by Core Prognostex, Inc. can be applied to other solid tumors including cancers of the prostate, lung, pancreas, ovary, and soft tissues. The products currently in use include the OP-Core Kit, the RAD-Core Kit and the OP-Core Device.